Vitton Veronique, Delpy Rene, Gasmi Mohamed, Lesavre Nathalie, Abou-Berdugo Einate, Desjeux Ariadne, Grimaud Jean-Charles, Barthet Marc
Department of Gastroenterology, Hôpital Nord, Chemin des Bourrely, Marseille cedex, France.
Eur J Gastroenterol Hepatol. 2008 Jan;20(1):15-21. doi: 10.1097/MEG.0b013e3282eeb4a1.
Endoscopic sphincterotomy is an efficient means of treating sphincter of Oddi dysfunction (SOD), but it is associated with a morbidity rate of 20%. The aim of this study was to assess how frequently endoscopic sphincterotomy was performed to treat SOD in a group of patients with a 1-year history of medical management.
A total of 59 patients, who had been cholecystectomized 9.3 years previously on average, were included in this study and they all underwent biliary scintigraphy. Medical treatment was prescribed for 1 year. Endoscopic sphincterotomy was proposed for patients whose medical treatment had been unsuccessful.
Eleven patients were rated group 1 on the Milwaukee classification scale, 34 group 2 and 14 group 3. The hile-duodenum transit time (HDTT) was lengthened in 32 patients. The medical treatment was efficient or fairly efficient in 45% of the group 1 patients, 67% of the group 2 patients, and 71.4% of the group 3 patients (P=0.29). Only 14 patients out of the 21 whose medical treatment was unsuccessful agreed to undergo endoscopic sphincterotomy. HDTT was lengthened in 11 of the 14 patients undergoing endoscopic sphincterotomy and in 21 of the 45 non-endoscopic sphincterotomy patients (P=0.03). Twelve of the 14 patients who underwent endoscopic sphincterotomy were cured.
In this prospective series of patients with a 1-year history of medical management, only 23% of the patients with suspected SOD underwent endoscopic sphincterotomy although 54% had an abnormally long HDTT.
内镜下括约肌切开术是治疗Oddi括约肌功能障碍(SOD)的有效方法,但它的发病率为20%。本研究的目的是评估在一组接受了1年药物治疗的患者中,内镜下括约肌切开术治疗SOD的频率。
本研究共纳入59例患者,他们平均在9.3年前接受了胆囊切除术,均接受了胆道闪烁显像检查。给予1年的药物治疗。对于药物治疗无效的患者建议行内镜下括约肌切开术。
根据密尔沃基分类量表,11例患者被评为1组,34例为2组,14例为3组。32例患者的肝十二指肠转运时间(HDTT)延长。1组45%的患者、2组67%的患者和3组71.4%的患者药物治疗有效或相当有效(P = 0.29)。在21例药物治疗无效的患者中,只有14例同意接受内镜下括约肌切开术。14例行内镜下括约肌切开术的患者中有11例HDTT延长,45例未行内镜下括约肌切开术的患者中有21例HDTT延长(P = 0.03)。14例行内镜下括约肌切开术的患者中有12例治愈。
在这个有1年药物治疗史的前瞻性患者系列中,尽管54%的患者HDTT异常延长,但只有23%疑似SOD的患者接受了内镜下括约肌切开术。